Skip to main content
Caplight Logo









KinSea Lead Discovery AS

KinSea Lead Discovery AS

Private
TromsøHealthcare & Life Scienceshttps://www.kinsea-lead-discovery.com/

Last Round

Grant

Mar 1, 2025

Total Funding Raised

$560,000

Company Overview

KinSea Lead Discovery AS is a biotechnology company that develops marine bioactive compounds into pharmaceutical products for the treatment of cancer and other diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

drug discoverybiopharmaceuticalFLT3 kinase inhibitoracute myeloid leukemiaAMLmarine bioactive compoundsbioprospectingpreclinical drug candidateoncology therapeuticshematologic cancerbiotech startupdrug licensingmarine biotechsmall molecule drug

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

KinSea Lead Discovery AS Comparables

Compare KinSea Lead Discovery AS with similar companies based on industry and business-model similarity.

KinSea Lead Discovery AS comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Arog Pharmaceuticals
78%
Daiichi Sankyo
72%
Novartis
68%

KinSea Lead Discovery AS Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 1, 2025
SeedApr 25, 2024

KinSea Lead Discovery AS Investors

Notable investors and investment history

KinSea Lead Discovery AS investors
InvestorRounds
Innovasjon NorgeGrant
NorinnovaSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 2, 2026

    Monthly visitors increased 78% MoM.

  • May 4, 2025

    Monthly visitors grew 208% MoM, reaching 1.2K.

KinSea Lead Discovery AS Filings

Explore SEC and related filing metadata, where available.

KinSea Lead Discovery AS filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about KinSea Lead Discovery AS's valuation, stock price, and market status.

Is KinSea Lead Discovery AS a public or private company?

KinSea Lead Discovery AS is a private company.

What is the current stock price of KinSea Lead Discovery AS?

KinSea Lead Discovery AS is a private company with no public stock price. No recent secondary market data is available.

How much is KinSea Lead Discovery AS worth (valuation)?

Valuation information for KinSea Lead Discovery AS is not publicly available.

Can I buy KinSea Lead Discovery AS stock?

KinSea Lead Discovery AS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was KinSea Lead Discovery AS's last funding round?

KinSea Lead Discovery AS's most recent funding round was Grant on March 1, 2025.

Who are the main investors in KinSea Lead Discovery AS?

Key investors in KinSea Lead Discovery AS include Innovasjon Norge, Norinnova.

Will KinSea Lead Discovery AS IPO soon?

No public IPO plans have been announced for KinSea Lead Discovery AS.

How can I track KinSea Lead Discovery AS secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor KinSea Lead Discovery AS's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTromsø
Employee Range1
Year Founded2022
Last FundingMar 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?